Description: Explore the role of inflation across health products, including medical plans, disability, and long-term care. Explore various drivers of cost trends, wage increase, and cost of care. Understand their role in the pricing and valuation of a product and how to manage the risk.

Description: The SOA Research Institute’s Living to 100 Symposium gathers researchers from many specialties, including demographers, medical researchers, academics, insurtechs and actuaries to discuss their latest research on longevity. Come check out the highlights from the 2023 symposium.

Description: The SOA Research Institute Catastrophe and Climate Strategic Research Program released a report that explores the shifting geography of Lyme Disease in the U.S. and beyond and some of the potential determinants of its spread. Lyme Disease is a well-known disease particularly in the eastern U.S., and it is also prevalent in other geographies. This report researches the complex relationship between climate variables and the spread of Lyme Disease in the United States.

Description: The true cost of a drug and its therapeutic outcome is impacted by a myriad of factors. This session will utilize case studies in high-cost, chronic diseases to illustrate to participants what factors can be critical to evaluating the true cost of a pharmaceutical intervention. Differing from session one, session two will focus on site of care, buy-and-bill aspects, and the differences between a medical and pharmacy benefit and how these factors ultimately impact the total cost of patient care.

Description: The use of data to assess risk is not new to the life insurance industry, but has historically been limited to leveraging structured data. Join us as we discuss the next frontier: unstructured data.

Description: Attendees will hear examples of individuals with medical conditions which are either being treated by gene therapy or have gene therapy treatments in development. Attendees will learn about what gene therapy is, current development methods, treatment efficacy, and expectations for future gene therapy treatments. We will explore funding challenges for gene therapy and potential methods to manage costs for gene therapy treatments.

Description: This session will explore a solution to manage health expenses, a bit like the retirement risk managed by the three-legged stool, that is coming from government benefits, employer pension plan, and registered retirement savings plan. The solution could be called a Registered Health Savings Account (RHSA), and could then complement public coverage, and group insurance coverage

Description: Value-based care models have to date been focused on either broad, total-cost-of-care, primary care-based models; or on a limited set of episodes of care. This session will focus on initiatives to bring these concepts together for improved outcomes for patients and greater savings from an integrated solution.

Description: When actuaries and consultants evaluate various pharmaceuticals for inclusion in an employer’s benefits offering, it can be commonplace to look at the advertised list price, or WAC (wholesale acquisition cost), between products and use that as a primary driver in the evaluation process.

Description: It's your first full day of productive learning! Start it off right with a delicious breakfast and warm welcome.